Zobrazeno 1 - 10
of 112
pro vyhledávání: '"D D, Weisenburger"'
Autor:
Joo Y. Song, Laura K. Hilton, Stefania Pittaluga, Catalina Amador, Brett Collinge, Timothy C. Greiner, David Scott, Lisa M. Rimsza, K. Fu, James R. Cook, T. Miyata-Takata, L. M. Staudt, Giorgio Inghirami, Kerry J. Savage, B. M. Grande, Pedro Farinha, Graham W. Slack, Klaus Beiske, Laurie H. Sehn, C. Steidl, Andrew J. Mungall, Ryan D. Morin, Andreas Rosenwald, Harald Holte, Elias Campo, Susana Ben-Neriah, A.L. Feldman, Elaine S. Jaffe, D. D. Weisenburger, Jan Delabie, W. C. Chan, German Ott, Philipp W. Raess
Publikováno v:
Hematological Oncology. 39
Autor:
Pedro Farinha, Stefania Pittaluga, L. M. Staudt, Christopher Rushton, Klaus Beiske, Catalina Amador, Joo Y. Song, James R. Cook, Susana Ben-Neriah, Andrew J. Mungall, C. Steidl, Elias Campo, Brett Collinge, W. C. Chan, J. Wong, Lisa M. Rimsza, Philipp W. Raess, A.L. Feldman, Harald Holte, Elaine S. Jaffe, Graham W. Slack, Laura K. Hilton, German Ott, Jan Delabie, Andreas Rosenwald, Kerry J. Savage, Ryan D. Morin, David Scott, D. D. Weisenburger, K. Fu, Giorgio Inghirami, Timothy C. Greiner
Publikováno v:
Hematological Oncology. 39
Autor:
Javeed Iqbal, Andreas Rosenwald, Kai Fu, Lisa M. Rimsza, Jan Delabie, Julie M. Vose, Anna Scuto, Randy D. Gascoyne, Elias Campo, Elaine S. Jaffe, Alyssa Bouska, Qiang Gong, Rita M. Braziel, German Ott, Weiwei Zhang, W. C. Chan, Jean M. Connors, Maja Ludvigsen, C. I. Wu, Timothy W. McKeithan, Francesco d'Amore, D. D. Weisenburger, Timothy C. Greiner, Louis M. Staudt
Publikováno v:
Leukemia
Bouska, A, Zhang, W, Gong, Q, Iqbal, J, Scuto, A, Vose, J, Ludvigsen, M, Fu, K, Weisenburger, D D, Greiner, T C, Gascoyne, R D, Rosenwald, A, Ott, G, Campo, E, Rimsza, L M, Delabie, J, Jaffe, E S, Braziel, R M, Connors, J M, Wu, C-I, Staudt, L M, D'Amore, F, McKeithan, T W & Chan, W C 2016, ' Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma ', Leukemia . https://doi.org/10.1038/leu.2016.175
Bouska, A, Zhang, W, Gong, Q, Iqbal, J, Scuto, A, Vose, J, Ludvigsen, M, Fu, K, Weisenburger, D D, Greiner, T C, Gascoyne, R D, Rosenwald, A, Ott, G, Campo, E, Rimsza, L M, Delabie, J, Jaffe, E S, Braziel, R M, Connors, J M, Wu, C-I, Staudt, L M, D'Amore, F, McKeithan, T W & Chan, W C 2016, ' Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma ', Leukemia . https://doi.org/10.1038/leu.2016.175
Follicular lymphoma (FL) is typically an indolent disease, but 30-40% of FL cases transform into an aggressive lymphoma (tFL) with a poor prognosis. To identify the genetic changes that drive this transformation, we sequenced the exomes of 12 cases w
Autor:
J Huo, Andreas Rosenwald, Christian Steidl, Kai Fu, Gloria E. O. Borgstahl, Randy D. Gascoyne, Qiang Gong, D. D. Weisenburger, Louis M. Staudt, Timothy C. Greiner, Yuping Li, Simon J. Davis, Joseph Rohr, Peter D. Simone, Andrew Cannon, Shuangping Guo, Anja Mottok, Wenming Xiao, Weiwei Zhang, Cynthia M. Lachel, Alyssa Bouska, Julie M. Vose, Tayla Heavican, Stacy Hung, Javeed Iqbal, Timothy W. McKeithan, Chao Wang, Wing C. Chan
Publikováno v:
Leukemia. 30:1062-1070
Peripheral T-cell lymphomas (PTCLs) comprise a heterogeneous group of mature T-cell neoplasms with a poor prognosis. Recently, mutations in TET2 and other epigenetic modifiers as well as RHOA have been identified in these diseases, particularly in an
Autor:
Andreas Rosenwald, Christian Steidl, Kai Fu, Colleen Ramsower, George Wright, Jan Delabie, D. D. Weisenburger, German Ott, Joo Y. Song, Erlend B. Smeland, Rita M. Braziel, Randy D. Gascoyne, John Chan, E. Campo, Anja Mottok, E. S. Jaffe, David W. Scott, Timothy C. Greiner, Lisa M. Rimsza, Harald Holte, Jean M. Connors, Betty Glinsmann-Gibson, James R. Cook, L. M. Staudt
Publikováno v:
Hematological Oncology. 35:59-60
Autor:
Patricia Aoun, Julie M. Vose, Javier A. Laurini, Jane Yuan, James O. Armitage, Bhavana J. Dave, Lynette M. Smith, Timothy C. Greiner, Bharat N. Nathwani, W. C. Chan, P. J. Bierman, D. D. Weisenburger, Kai Fu, R. El Behery, Robert G. Bociek
Publikováno v:
Hematological Oncology. 35:285-286
Autor:
Matthew J. Maurer, Julie M. Vose, Jean-Philippe Jais, Hervé Tilly, Shigeo Nakamura, A.L. Feldman, David Sibon, D. Nguyen, Laurence Lamant, Kerry J. Savage, Martin Bast, Norbert Schmitz, Remy Gressin, Ritsuro Suzuki, Marita Ziepert, James O. Armitage, D. D. Weisenburger
Publikováno v:
Hematological Oncology. 35:240-240
Autor:
B Coiffier, HK Muller-Hermelink, J Close, Kenneth A. MacLennan, P Jacobs, Pooja Roy, D. D. Weisenburger, J Connors, F Cavalli, E Pedrinis, James O. Armitage, Randy D. Gascoyne, Fcs Ho, G Ott, Rhs Liang, TA Lister, A Schauer, Françoise Berger, N Harris, Bharat N. Nathwani, W Hiddemann, J Diebold, WC Chan, Anderson, A Norton
Publikováno v:
Annals of Oncology. 8:973-978
Autor:
John C. Chan, Giorgio Inghirami, Maria Antonella Laginestra, Fabio Fuligni, Pier Paolo Piccaluga, Javeed Iqbal, Maria Rosaria Sapienza, Pier Luigi Zinzani, Martin L. Hansmann, Monica Bellei, Claudio Agostinelli, Julie M. Vose, Francesco Bacci, Massimo Federico, Claudia Mannu, Sylvia Hartmann, Stefano Pileri, Antonio De Leo, Elena Sabattini, D. D. Weisenburger, Maura Rossi, Clara Bertuzzi, Roberto Piva, Anna Gazzola
Publikováno v:
Europe PubMed Central
Purpose The differential diagnosis among the commonest peripheral T-cell lymphomas (PTCLs; ie, PTCL not otherwise specified [NOS], angioimmunoblastic T-cell lymphoma [AITL], and anaplastic large-cell lymphoma [ALCL]) is difficult, with the morphologi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0eb745e75e4aad74541f16242ca51bef
http://hdl.handle.net/2318/136249
http://hdl.handle.net/2318/136249
Autor:
Martin Bast, D. D. Weisenburger, Anne Kessinger, Julie M. Vose, E. I. Ruby, James O. Armitage, Douglas A. Stewart, Philip J. Bierman, James R. Anderson
Publikováno v:
Annals of Oncology. 6:263-266
Summary Background Although mantle cell lymphoma (MCL) is a distinct disease entity with well described clinical and pathological features, little information exists regarding its therapy. This paper will evaluate patients with MCLreceiving either in